Literature DB >> 2582591

Acetylcholine causes coronary vasodilation in dogs and baboons.

D M Van Winkle1, E O Feigl.   

Abstract

Intracoronary administration of acetylcholine or efferent vagal stimulation causes coronary vasodilation in dogs. However, in baboons it has been reported that intracoronary acetylcholine results in a fall in coronary blood flow and that stimulation of the vagi is without effect. The dose response of intracoronary acetylcholine and the effect of efferent vagal stimulation on the coronary circulation were reinvestigated in closed-chest, anesthetized dogs and baboons. The left main coronary artery was cannulated and perfused at constant pressure. alpha-Adrenergic and beta-adrenergic receptors were pharmacologically blocked with phenoxybenzamine and propranolol. Heart rate was held constant by right ventricular pacing. In dogs, intracoronary infusion of acetylcholine (1-300 micrograms/min) elicited a dose-dependent increase in steady-state coronary blood flow and coronary sinus oxygen tension, without a change in myocardial oxygen consumption. Vagal stimulation caused a coronary vasodilation that was attenuated by a metabolically mediated decrease in flow. In baboons, acetylcholine increased steady-state coronary blood flow in the dose range of 1-10 micrograms/min, caused little change at 30 micrograms/min, and decreased flow at 100-300 micrograms/min. Coronary sinus oxygen tension increased in a dose-dependent manner up to 10 micrograms/min. Myocardial oxygen consumption was unchanged in the dose range of 1-10 micrograms/min and declined between 30 and 300 micrograms/min. Efferent stimulation of the vagi resulted in coronary dilation obscured by a metabolic reduction of flow. It is concluded that 1) low doses of acetylcholine elicit a primary coronary vasodilation in both species, but in baboons high doses of acetylcholine cause a reduction of both myocardial oxygen consumption and coronary blood flow below control values and 2) vagal stimulation causes a competition between coronary vasodilation and metabolic reduction of flow in dogs and baboons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582591     DOI: 10.1161/01.res.65.6.1580

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart.

Authors:  A Saeki; F A Recchia; H Senzaki; D A Kass
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

Review 3.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 4.  Metabolic regulation of in vivo myocardial contractile function: multiparameter analysis.

Authors:  M D Osbakken
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

5.  Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.

Authors:  U Simonsen; D Prieto; L Rivera; M Hernández; M J Mulvany; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

6.  Chronic activation of hypothalamic oxytocin neurons improves cardiac function during left ventricular hypertrophy-induced heart failure.

Authors:  Kara Garrott; Jhansi Dyavanapalli; Edmund Cauley; Mary Kate Dwyer; Sarah Kuzmiak-Glancy; Xin Wang; David Mendelowitz; Matthew W Kay
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

7.  Activation of Oxytocin Neurons Improves Cardiac Function in a Pressure-Overload Model of Heart Failure.

Authors:  Jhansi Dyavanapalli; Jeannette Rodriguez; Carla Rocha Dos Santos; Joan B Escobar; Mary Kate Dwyer; John Schloen; Kyung-Min Lee; Whitney Wolaver; Xin Wang; Olga Dergacheva; Lisete C Michelini; Kathryn J Schunke; Christopher F Spurney; Matthew W Kay; David Mendelowitz
Journal:  JACC Basic Transl Sci       Date:  2020-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.